Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -0.56%60.64M | -7.66%114.9M | 5.43%60.98M | 80.11%124.42M | 73.34%57.84M | -6.30%69.08M | -2.92%33.37M | -3.34%73.73M | -3.50%34.37M | 6.67%76.28M |
| Operating income | -0.56%60.64M | -7.66%114.9M | 5.43%60.98M | 80.11%124.42M | 73.34%57.84M | -6.30%69.08M | -2.92%33.37M | -3.34%73.73M | -3.50%34.37M | 6.67%76.28M |
| Cost of sales | 17.73%-33.07M | 2.96%-76.37M | 7.26%-40.19M | -80.85%-78.7M | -79.14%-43.34M | 4.26%-43.52M | -8.22%-24.19M | 2.12%-45.45M | -10.30%-22.35M | -21.87%-46.44M |
| Operating expenses | 17.73%-33.07M | 2.96%-76.37M | 7.26%-40.19M | -80.85%-78.7M | -79.14%-43.34M | 4.26%-43.52M | -8.22%-24.19M | 2.12%-45.45M | -10.30%-22.35M | -21.87%-46.44M |
| Gross profit | 32.64%27.57M | -15.74%38.53M | 43.34%20.79M | 78.84%45.72M | 58.05%14.5M | -9.58%25.57M | -23.65%9.18M | -5.24%28.28M | -21.71%12.02M | -10.66%29.84M |
| Selling expenses | 5.10%-2.38M | 36.81%-6.45M | 41.27%-2.51M | -30.95%-10.21M | -12.06%-4.27M | 15.36%-7.8M | -5.50%-3.81M | 10.81%-9.21M | -3.20%-3.62M | 11.45%-10.33M |
| Administrative expenses | -18.46%-9.88M | -19.07%-19.74M | -2.70%-8.34M | 0.46%-16.58M | -14.42%-8.12M | 2.20%-16.66M | 17.40%-7.1M | -5.99%-17.03M | -7.52%-8.59M | 10.48%-16.07M |
| Research and development expenses | 23.51%-2.03M | 1.43%-4.61M | -77.20%-2.66M | -8.05%-4.67M | 5.72%-1.5M | 4.08%-4.32M | -56.44%-1.59M | -16.37%-4.51M | 64.09%-1.02M | -20.20%-3.87M |
| Impairment and provision | ---- | -135.40%-114K | ---- | 666.67%322K | ---- | 126.25%42K | ---- | 89.11%-160K | ---- | -3,965.79%-1.47M |
| -Other impairment is provision | ---- | -135.40%-114K | ---- | 666.67%322K | ---- | 126.25%42K | ---- | 89.11%-160K | ---- | -3,965.79%-1.47M |
| Special items of operating profit | 18.17%2.31M | -18.46%2.72M | 70.36%1.95M | 29.20%3.33M | -24.14%1.15M | -57.02%2.58M | -33.36%1.51M | 36.79%6M | 20.31%2.27M | 16.30%4.39M |
| Operating profit | 68.81%15.59M | -42.33%10.33M | 426.64%9.23M | 3,147.28%17.92M | 196.53%1.75M | -117.46%-588K | -271.00%-1.82M | 35.21%3.37M | -63.49%1.06M | -43.11%2.49M |
| Earning before tax | 68.81%15.59M | -42.33%10.33M | 426.64%9.23M | 3,147.28%17.92M | 196.53%1.75M | -117.46%-588K | -271.00%-1.82M | 35.21%3.37M | -63.49%1.06M | -43.11%2.49M |
| Tax | -50.69%-2.53M | 24.33%-3.3M | -76.71%-1.68M | -145.63%-4.36M | -345.54%-949K | 32.94%-1.78M | -134.47%-213K | 19.15%-2.65M | 138.46%618K | 10.94%-3.27M |
| After-tax profit from continuing operations | 72.84%13.06M | -48.11%7.04M | 839.68%7.56M | 673.76%13.56M | 139.63%804K | -427.74%-2.36M | -220.77%-2.03M | 192.08%721K | 29.03%1.68M | -211.38%-783K |
| Earning after tax | 72.84%13.06M | -48.11%7.04M | 839.68%7.56M | 673.76%13.56M | 139.63%804K | -427.74%-2.36M | -220.77%-2.03M | 192.08%721K | 29.03%1.68M | -211.38%-783K |
| Profit attributable to shareholders | 72.84%13.06M | -48.11%7.04M | 839.68%7.56M | 673.76%13.56M | 139.63%804K | -427.74%-2.36M | -220.77%-2.03M | 192.08%721K | 29.03%1.68M | -211.38%-783K |
| Basic earnings per share | 72.34%0.0162 | -47.93%0.0088 | 840.00%0.0094 | 682.76%0.0169 | 140.00%0.001 | -422.22%-0.0029 | -219.05%-0.0025 | 190.00%0.0009 | 5.00%0.0021 | -211.11%-0.001 |
| Diluted earnings per share | -47.93%0.0088 | 682.76%0.0169 | -0.0029 | |||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Touche Tohmatsu CPA LLP | -- | Deloitte Touche Tohmatsu CPA LLP | -- | Deloitte Touche Tohmatsu CPA LLP | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Touche Tohmatsu CPA LLP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.